Inhibrx Biosciences, Inc. Common Stock
$101.77
-$3.84 (-3.64%)
$99.06Day Range$106.44
Key Statistics
Market Cap
$1.55B
Shares Outstanding
14.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 28, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$105.61
Day High
$106.44
Day Low
$99.06
Volume
363.5K
VWAP
$102.08
Prev Close
$105.61
Transactions
--
Acc. Volume
--
About Inhibrx Biosciences, Inc. Common Stock
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836110 employees11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037(858) 795-4220IPO May 28, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0002007919
- Composite FIGI
- BBG01MS5Q9G3
- Share Class FIGI
- BBG01MS5QB96
- Ticker Root
- INBX
- SIC Code
- 2836
About Inhibrx Biosciences, Inc. Common Stock (INBX) Stock
Inhibrx Biosciences, Inc. Common Stock (INBX) closed the 2026-09-16 session at $101.77, down 3.64% versus the previous close (-3.84). The stock opened at $105.61 and traded between $99.06 and $106.44 during that session. Session trading volume was 363K shares. The volume-weighted average price (VWAP) is $102.08.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
Inhibrx Biosciences, Inc. Common Stock has a market capitalization of $1.55 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. INBX is listed on the XNAS exchange. The company employs approximately 110 people. Inhibrx Biosciences, Inc. Common Stock is headquartered in LA JOLLA, CA. The recorded listing date is 2024-05-28.
On this page you can find market INBX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.